Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis.
Mult Scler Relat Disord
; 52: 103006, 2021 Jul.
Article
in En
| MEDLINE
| ID: mdl-34004435
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Multiple Sclerosis
Limits:
Humans
Language:
En
Year:
2021
Type:
Article